INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
Portfolio Pulse from
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased APLT securities between January 3, 2024, and December 2, 2024, have until February 18, 2025, to seek lead plaintiff status.
February 13, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics, Inc. faces a class action lawsuit for alleged violations of the Securities Exchange Act of 1934. Investors have until February 18, 2025, to seek lead plaintiff status.
The announcement of a class action lawsuit against Applied Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for investors to seek lead plaintiff status adds urgency to the situation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100